Frederik G. Hansson

This paper demonstrates the production of galantamine in yeast through pathway engineering and optimization, achieving a 173-fold improvement over the parental strain.

This study engineering yeast to produce kratom monoterpene indole alkaloids through synthetic pathway reconstruction and optimization, achieving a titer of ~290 µg/L.

The paper introduces a model called CSNN that uses network homophily to improve in-distribution predictions of drug-target interactions for human GPCRs.